SCHEMBL20428982

SCHEMBL20428982

C=C(C)c1csc(C(=O)NCC(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.39
MEN1 O00255 1/20 0.39
RAB9A P51151 7/20 0.39
HPGD P15428 5/20 0.39
NPC1 O15118 5/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
MLYCD O95822 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
TAS1R2 Q8TE23 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
CYP2C19 P33261 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL162901 0.78 KMT2A (0.44) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL15204826 0.78 KMT2A (0.44) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL20428951 0.77 GRM5 (0.49) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL20429001 0.77 GAA (0.40) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL24130265 0.76 ALDH1A1 (0.39) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL159632 0.73 RAB9A (0.47) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL19886205 0.69 RAB9A (0.43) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL1677251 0.69 NPC1 (0.60) KMT2AGAAHSD17B10SMN1; SMN2MEN1
SCHEMBL21534725 0.69 PLA2G4A (0.32) LMNA
SCHEMBL9331208 0.68 HDAC3 (0.46) KMT2AGAAHSD17B10MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354651-A1 TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF ROR-GAMMA-T Janssen Pharmaceutica N.V. (BE) 2018-08-01 EP disclosed